The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Progress Toward Hepatitis C Virus Elimination: Therapy and Implementation
Gastroenterol Clin North Am. 2020 Jun;49(2):253-277.doi: 10.1016/j.gtc.2020.01.005. Epub 2020 Mar 29.
1Viral Hepatitis Clinical Research Program, The Kirby Institute, UNSW Sydney, Sydney, Australia. Electronic address: mmartinello@kirby.unsw.edu.au.
2Viral Hepatitis Clinical Research Program, The Kirby Institute, UNSW Sydney, Sydney, Australia.
Abstract
The World Health Organization has called for the elimination of hepatitis C virus (HCV) as a public health threat by 2030. Highly effective direct-acting antiviral agents provide the therapeutic tools required for elimination. In the absence of a vaccine, HCV elimination will require enhanced primary prevention and an increase in the proportions of people diagnosed and treated. Given that globally only 20% of people with chronic HCV are diagnosed, and around 5% have initiated HCV treatment, the task ahead is enormous. But, global public health needs optimism, and countries currently on track for HCV elimination provide a pathway forward.